22 Sep 2015

Constraints on global supply of BCG vaccine

The WHO has called on all countries to take action to reduce wastage and ensure that high risk groups are prioritised Constraints on global supply of BCG vaccine

Due to on-going constraints with the global supply of BCG vaccine, the World Health Organization (WHO) has called on all countries to reduce BCG vaccine wastage [1], to ensure that countries with the highest TB rates receive priority and to target individuals who will benefit most from BCG vaccination. The WHO statement can be accessed here.

Providers of BCG vaccine are encouraged to organise the administration of BCG vaccinations in ways that optimise the use of the current multi-dose vials, for example by scheduling patients requiring BCG into the same clinic. Public Health England (PHE) supports the WHO statement to limit BCG vaccination to neonates and infants of recognised high-risk groups for tuberculosis or to tuberculin-negative children under five years of age. For further information on priority groups please check PHE guidance.


Medical product alert: falsified rabies vaccine - Philippines

A report of falsified rabies vaccine circulating in the Philippines Read more

NaTHNaC Webinar: update

Getting to grips with common clinical queries to the advice line Read more

Updated guidelines for malaria prevention in travellers from the UK: 2018

Public Health England (PHE) Advisory Committee on Malaria Prevention (ACMP) has published updated malaria guidelines Read more

Annual Return for Yellow Fever Vaccination Centres 1 Jan – 31 Dec 2018

The Annual Return for YFVC in England, Wales and Northern Ireland is OPEN Read more

Mozambique: cVDPV – recommendation for polio vaccination

Circulating vaccine-derived poliovirus (cVDPV) is confirmed in a community in Mozambique Read more
Back to Top